ETF Holdings Breakdown of ERAS

News associated with ERAS

MetLife Investment Management LLC Buys 9,039 Shares of Erasca, Inc. (NASDAQ:ERAS)

MetLife Investment Management LLC increased its stake in Erasca, Inc. (NASDAQ:ERAS – Free Report) by 8.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 112,725 shares of the company’s stock after purchasing an additional 9,039 shares during the period. MetLife Investment Management LLC’s holdings in […] - 2025-05-08 08:02:47

Erasca, Inc. (NASDAQ:ERAS) Shares Purchased by Barclays PLC

Barclays PLC raised its stake in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) by 9.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 377,764 shares of the company’s stock after acquiring an additional 33,834 shares during the quarter. Barclays PLC’s holdings in […] - 2025-05-06 08:12:45

Invesco Ltd. Buys 11,290 Shares of Erasca, Inc. (NASDAQ:ERAS)

Invesco Ltd. boosted its position in Erasca, Inc. (NASDAQ:ERAS – Free Report) by 30.2% in the 4th quarter, Holdings Channel reports. The institutional investor owned 48,671 shares of the company’s stock after purchasing an additional 11,290 shares during the period. Invesco Ltd.’s holdings in Erasca were worth $122,000 at the end of the most recent […] - 2025-05-06 08:12:45

Renaissance Technologies LLC Has $2.84 Million Holdings in Erasca, Inc. (NASDAQ:ERAS)

Renaissance Technologies LLC trimmed its holdings in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) by 12.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,133,000 shares of the company’s stock after selling 158,000 shares during the period. Renaissance Technologies LLC owned approximately 0.40% of […] - 2025-04-25 08:54:48

Erasca, Inc. (NASDAQ:ERAS) Holdings Increased by Geode Capital Management LLC

Geode Capital Management LLC increased its stake in Erasca, Inc. (NASDAQ:ERAS – Free Report) by 1.5% in the 4th quarter, HoldingsChannel reports. The fund owned 4,569,819 shares of the company’s stock after acquiring an additional 67,121 shares during the period. Geode Capital Management LLC’s holdings in Erasca were worth $11,474,000 at the end of the […] - 2025-04-23 07:26:59

Wellington Management Group LLP Invests $1.17 Million in Erasca, Inc. (NASDAQ:ERAS)

Wellington Management Group LLP purchased a new stake in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor purchased 465,672 shares of the company’s stock, valued at approximately $1,169,000. Several other large investors have also made changes to their positions in the company. Barclays PLC lifted its […] - 2025-04-14 08:27:01

Head-To-Head Contrast: Erasca (NASDAQ:ERAS) and Merck KGaA (OTCMKTS:MKGAF)

Merck KGaA (OTCMKTS:MKGAF – Get Free Report) and Erasca (NASDAQ:ERAS – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk. Analyst Ratings This is a breakdown of current ratings […] - 2025-04-10 06:07:11

Erasca (NASDAQ:ERAS) Coverage Initiated at Raymond James

Equities research analysts at Raymond James started coverage on shares of Erasca (NASDAQ:ERAS – Get Free Report) in a research note issued on Wednesday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $5.00 price target on the stock. Raymond James’ price target indicates a potential upside of 222.58% from the stock’s previous […] - 2025-03-28 06:52:43

Intech Investment Management LLC Purchases 34,083 Shares of Erasca, Inc. (NASDAQ:ERAS)

Intech Investment Management LLC increased its holdings in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) by 53.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 97,369 shares of the company’s stock after buying an additional 34,083 shares during the quarter. Intech Investment Management […] - 2025-03-27 08:28:55

Bank of New York Mellon Corp Increases Stake in Erasca, Inc. (NASDAQ:ERAS)

Bank of New York Mellon Corp boosted its position in shares of Erasca, Inc. (NASDAQ:ERAS – Free Report) by 6.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 544,819 shares of the company’s stock after purchasing an additional 35,268 shares during the period. Bank of New York Mellon Corp’s holdings in Erasca were worth […] - 2025-03-24 08:22:47

Erasca (NASDAQ:ERAS) Price Target Lowered to $3.00 at The Goldman Sachs Group

Erasca (NASDAQ:ERAS – Free Report) had its price target trimmed by The Goldman Sachs Group from $3.50 to $3.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other research firms also recently issued reports on ERAS. Bank of America upgraded Erasca from […] - 2025-03-24 06:12:55

Reviewing Erasca (NASDAQ:ERAS) & Allakos (NASDAQ:ALLK)

Erasca (NASDAQ:ERAS – Get Free Report) and Allakos (NASDAQ:ALLK – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability. Profitability This table compares Erasca and Allakos’ net margins, […] - 2025-02-05 06:06:46

ERAS institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	77,158	USD 107,250
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	142,158	USD 197,600
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	142,158	USD 197,600 11.9%
2025-05-08	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,691	USD 2,350
Total =		363,165	USD 504,800

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer